182 related articles for article (PubMed ID: 26908324)
1. Analgesic medication use and risk of epithelial ovarian cancer in African American women.
Peres LC; Camacho F; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry P; Wang F; Schildkraut JM
Br J Cancer; 2016 Mar; 114(7):819-25. PubMed ID: 26908324
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
3. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
[TBL] [Abstract][Full Text] [Related]
4. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N;
J Natl Cancer Inst; 2014 Feb; 106(2):djt431. PubMed ID: 24503200
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic features of borderline ovarian tumors in California: a population-based study.
Morris CR; Liu L; Rodriguez AO; Cress RD; Snipes K
Cancer Causes Control; 2013 Apr; 24(4):665-74. PubMed ID: 23314731
[TBL] [Abstract][Full Text] [Related]
6. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.
Trabert B; Poole EM; White E; Visvanathan K; Adami HO; Anderson GL; Brasky TM; Brinton LA; Fortner RT; Gaudet M; Hartge P; Hoffman-Bolton J; Jones M; Lacey JV; Larsson SC; Mackenzie GG; Schouten LJ; Sandler DP; O'Brien K; Patel AV; Peters U; Prizment A; Robien K; Setiawan VW; Swerdlow A; van den Brandt PA; Weiderpass E; Wilkens LR; Wolk A; Wentzensen N; Tworoger SS;
J Natl Cancer Inst; 2019 Feb; 111(2):137-145. PubMed ID: 29860330
[TBL] [Abstract][Full Text] [Related]
7. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
8. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).
Staples JN; Peres LC; Camacho F; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
Gynecol Oncol; 2020 Jul; 158(1):123-129. PubMed ID: 32362566
[TBL] [Abstract][Full Text] [Related]
11. Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.
Setiawan VW; Matsuno RK; Lurie G; Wilkens LR; Carney ME; Henderson BE; Kolonel LN; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1441-9. PubMed ID: 22665579
[TBL] [Abstract][Full Text] [Related]
12. Aspirin, other NSAIDs, and ovarian cancer risk (United States).
Fairfield KM; Hunter DJ; Fuchs CS; Colditz GA; Hankinson SE
Cancer Causes Control; 2002 Aug; 13(6):535-42. PubMed ID: 12195643
[TBL] [Abstract][Full Text] [Related]
13. Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium.
Webb PM; Na R; Weiderpass E; Adami HO; Anderson KE; Bertrand KA; Botteri E; Brasky TM; Brinton LA; Chen C; Doherty JA; Lu L; McCann SE; Moysich KB; Olson S; Petruzella S; Palmer JR; Prizment AE; Schairer C; Setiawan VW; Spurdle AB; Trabert B; Wentzensen N; Wilkens L; Yang HP; Yu H; Risch HA; Jordan SJ
Ann Oncol; 2019 Feb; 30(2):310-316. PubMed ID: 30566587
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract][Full Text] [Related]
15. Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis.
Verdoodt F; Kjaer SK; Friis S
Maturitas; 2017 Jun; 100():1-7. PubMed ID: 28539172
[TBL] [Abstract][Full Text] [Related]
16. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
Dixon SC; Nagle CM; Wentzensen N; Trabert B; Beeghly-Fadiel A; Schildkraut JM; Moysich KB; deFazio A; ; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Ness RB; Edwards RP; Jensen A; Kjær SK; Høgdall E; Berchuck A; Cramer DW; Terry KL; Poole EM; Bandera EV; Paddock LE; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Webb PM
Br J Cancer; 2017 Apr; 116(9):1223-1228. PubMed ID: 28350790
[TBL] [Abstract][Full Text] [Related]
17. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536
[TBL] [Abstract][Full Text] [Related]
18. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
Mills PK; Riordan DG; Cress RD; Young HA
Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study.
Prizment AE; Folsom AR; Anderson KE
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):435-42. PubMed ID: 20142241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
